About Tissue Informatic
Tissue Informatic is a company based in Pittsburgh (United States) founded in 1998 by Michael Becich, Peter C Johnson, and Daniel L Farkas was acquired by BioImagene in June 2006.. Tissue Informatic has raised $12.5 million across 2 funding rounds from investors including Motorola Mobility, Manulife and BioImagene. Tissue Informatic operates in a competitive market with competitors including PathAI, Deepcell, Aignostics, Pictor Labs and Neko Health, among others.
- Headquarter Pittsburgh, United States
- Founders Michael Becich, Peter C Johnson, Daniel L Farkas
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$12.5 M (USD)
in 2 rounds
-
Latest Funding Round
$12.5 M (USD), Series B
Jan 24, 2002
-
Investors
Motorola Mobility
& 4 more
-
Employee Count
Employee Count
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Tissue Informatic
Tissue Informatic has successfully raised a total of $12.5M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $12.5 million completed in January 2002. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series B — $12.5M
- First Round First Round
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2002 | Amount | Series B - Tissue Informatic | Valuation | TVM Capital | |
| Apr, 2000 | Amount | Series B - Tissue Informatic | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Tissue Informatic
Tissue Informatic has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Motorola Mobility, Manulife and BioImagene. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Capital is invested in life science innovations for healthcare transformation.
|
Founded Year | Domain | Location | |
|
Life insurance and diversified asset management services are provided.
|
Founded Year | Domain | Location | |
|
Mobile devices, cases, tablets, and screen protectors are offered online.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Tissue Informatic
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Tissue Informatic
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Tissue Informatic Comparisons
Competitors of Tissue Informatic
Tissue Informatic operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as PathAI, Deepcell, Aignostics, Pictor Labs and Neko Health, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of AI-based solutions for clinical diagnosis of cancer and other diseases
|
|
| domain | founded_year | HQ Location |
AI-powered single cell classification and isolation technology for clinical research
|
|
| domain | founded_year | HQ Location |
AI-based pathology diagnostic software is provided for medical analysis.
|
|
| domain | founded_year | HQ Location |
AI-based tools for pathological image analysis are provided to labs.
|
|
| domain | founded_year | HQ Location |
Platform offering solutions for preventive health scans
|
|
| domain | founded_year | HQ Location |
Provides image analysis and data mining solutions for quantitative digital pathology in the healthcare industry
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Tissue Informatic
When was Tissue Informatic founded?
Tissue Informatic was founded in 1998 and raised its 1st funding round 2 years after it was founded.
Where is Tissue Informatic located?
Tissue Informatic is headquartered in Pittsburgh, United States. It is registered at Pittsburgh, Pennsylvania, United States.
Is Tissue Informatic a funded company?
Tissue Informatic is a funded company, having raised a total of $12.5M across 2 funding rounds to date.
What does Tissue Informatic do?
Tissue Informatic was founded in 1998 in Pittsburgh, United States, and operates within the biotechnology sector. Automated quantitative analysis of tissues is facilitated through technologies for image capture, analysis, and morphology assessment. These systems support research and applications in tissue imaging for the industry, with core operations centered on enabling precise evaluation of biological samples.
Who are the top competitors of Tissue Informatic?
Tissue Informatic's top competitors include Aignostics, Pictor Labs and PathAI.
Who are Tissue Informatic's investors?
Tissue Informatic has 4 investors. Key investors include Motorola Mobility, Manulife, BioImagene, and TVM Capital Life Science.